Improvements in the state of healthcare quality revealed
According to NCQA's annual State of Health Care Quality, improvements in measures related to high blood pressure and cholesterol control for people with diabetes were made compared with previous statistics. "High blood pressure is very common and, unfortunately, has been poorly controlled," says Earl Steinberg, MD, MPP, president and CEO of Resolution Health, a healthcare data analysis company that provides quality improvement and cost reduction services. "There is tremendous room for improvement on this measure. In addition, high blood pressure is something that the public understands. As a result, when public attention was focused upon this measure in 1999, health plans began efforts to improve blood pressure control-and those efforts are paying off."
NCQA's report shows that huge variations in quality remain commonplace. "Quality gap" is a term NCQA has coined to describe the gap in performance between the national average for a given performance measure and the rate achieved by the top 10% of health plans.
"For example, among the top 10% of health plans, about 68% of people who have had a heart attack have their cholesterol appropriately controlled," says Greg Pawlson, MD, NCQA's executive vice president. "But estimates of the national average for all persons say only about 50% [have it controlled]. So there's an 18 percentage point 'quality gap' between the two. It's important to track these gaps because they really represent the difference between what we could achieve if everyone were getting care in high-quality systems, and what we actually achieve. In this case we know that 68% is a reasonable target because many plans and practices already operate at that level. We also use these gaps to estimate how many lives might be saved if everyone received care through a top performing plan. The numbers are staggering: between 37,000 and 80,000 lives every year."
"Organizations that offer higher quality of care have a substantial advantage over their competitors and not just in terms of marketing and member loyalty. In the long run, it's better value for everyone to deliver high quality care, in terms of quality, cost and efficiency. You don't have to prevent a lot of second heart attacks or strokes to make controlling people's blood pressure and cholesterol a worthwhile investment," Dr. Pawlson says.
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
Study Raises Concerns Over Insurance Barriers to HIV Prevention Medications
November 29th 2023Despite its efficacy, PrEP remains underutilized compared to the need for it. High costs are among the barriers to PrEP use, along with limited knowledge among clinicians, lack of health insurance, stigma, and underestimation of personal HIV risk.
Read More